A detailed history of Dynamic Technology Lab Private LTD transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 14,085 shares of ALLO stock, worth $40,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,085
Holding current value
$40,987
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.23 - $4.38 $31,409 - $61,692
14,085 New
14,085 $33,000
Q2 2023

Aug 14, 2023

BUY
$4.53 - $6.74 $149,920 - $223,060
33,095 New
33,095 $164,000
Q3 2022

Nov 14, 2022

BUY
$10.32 - $17.28 $479,384 - $802,690
46,452 New
46,452 $501,000
Q3 2022

Nov 14, 2022

BUY
$10.32 - $17.28 $479,384 - $802,690
46,452 New
46,452 $501,000
Q3 2021

Nov 15, 2021

SELL
$21.01 - $27.64 $166,399 - $218,908
-7,920 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$23.49 - $35.8 $186,040 - $283,536
7,920 New
7,920 $207,000

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $418M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.